Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Loh Evan. Officer active across 2 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 16 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €211k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
1,069,231 sharesCommon StockSEC:0000899243-23-019351:0
168,750 shares0Common StockSEC:0000904454-23-000472:0
52,500 shares0Common StockSEC:0000904454-22-000653:0
37,831 shares@ US$1.9833.7% of flowCommon StockSEC:0000904454-22-000627:0
8,805 shares@ US$3.4714.5% of flowCommon StockSEC:0000904454-22-000532:0
30,000 shares0Common StockSEC:0000904454-22-000510:0
152,727 shares0Common StockSEC:0000904454-22-000429:0
236,250 shares0Common StockSEC:0000904454-22-000268:0
6,000 shares0Common StockSEC:0001140361-22-009258:0
13,983 shares@ US$4.4225.9% of flowCommon StockSEC:0000904454-21-000840
13,983 shares@ US$4.4250.0% of flowCommon StockSEC:0000904454-21-000840:0
75,000 shares0Common StockSEC:0000904454-21-000630:0
75,000 shares0Common StockSEC:0000904454-21-000630
91,636 shares0Common StockSEC:0000904454-21-000512:0
91,636 shares0Common StockSEC:0000904454-21-000512
22,500 sharesCommon StockSEC:0000904454-16-000926:0
About Loh Evan
Loh Evan is a director at Paratek Pharmaceuticals, Inc. and also involved with Eiger BioPharmaceuticals, Inc.